“TANGO” nocturia scanning tool: Turkish validity and reliability study

Abstract

Background: The aim of this study is to evaluate the validity and reliability of the Targeting the Individual's Aetiology of Nocturia to Guide Outcomes (TANGO) screening tool, which is used to determine nocturia etiology. Methods: Patients hospitalized in urology, orthopedics, and general surgery clinics between September 2019 and January 2020 were included in the study. Demographic characteristics of the participants such as age, gender, drug use, and nocturia severity were assessed by the researchers. The Turkish version of the TANGO questionnaire consisting of 22 questions was filled in by the patients. The patients were asked to repeat the same test 4 weeks later. Results: A total of 124 patients were included in the study. The mean age of the patients participating in the study was 51.20 ± 18.50 (38-82). The result of the reliability assessment showed that the total score intraclass correlation coefficient was 0.715 (individual item score weighted kappa coefficients, 0.696-0.731) and the Cronbach's alpha coefficient was 0.727. A total of 112 patients filled in the TANGO screening tool again after 4 weeks. The test-retest reliability analysis kappa value was 0.75 (0.68-0.83). In the validity analysis, a moderately positive correlation was observed between the TANGO-Urinary Incontinence Score and the number of nocturia (r = 0.452, P = .003). Conclusion: According to the validation study, the TANGO screening tool is valid and reliable to determine the nocturia etiology for the Turkish population.

Translation and Validation of the TANGO Nocturia Screening Tool into Greek

“…4 In the paper of Culha et al there was a single group of 124 patients presenting a total Kappa value of 0.715 (individual item score weighted kappa coefficients, 0.696-0.731). 6 There is a strong correlation between nocturia and the nocturia index in men seeking LUTS treatment or in community-dwellers with or without LUTS. It has been supposed that the severity of nocturia correlates poorly with maximum bladder storage during the night but moderately corresponds with nocturnal polyuria.…”

“…However, Culha et al described the same methodology in validating TANGO questionnaire in the Turkish language. 6 Finally, a possible limitation is that patients and community-dwellers were not evaluated with the translated questionnaire after the prescribed nocturia management.…”

“…4 Three validated translations are already available; Dutch, Turkish and the Arabian Peninsula dialect. [5][6][7] The present study aimed to create a Greek version of TANGO (ie TANGO-Gr) and validate its relative reliability in prospective samples of community dwellers and rehabilitation centre (RC) residents. In terms of nocturia severity, these groups were considered to be representative of patients at both ends of the scale, making them suitable for determining validity.…”

The effect of long‐term COVID‐19 on aetiological factors related to nocturia

“…Nocturia is one of the lower urinary tract symptoms, which negatively affects patients' quality of life by causing frequent awakening at night but can be controlled when its cause is identified and treated (Culha et When the nocturia effects of long-term COVID-19 were examined according to the TANGO tool in this study, urinary tract was found as the 'priority' aetiological condition, which was followed by sleep, well-being, and cardio-metabolic factors. Items under the 'Urinary tract' factor on the TANGO nocturia screening tool express the presence of voiding dysfunction due to OAB and enlargement of the prostate and the frequency of nocturia (Bower et al, 2017;Culha et al, 2021). Some studies have shown that symptoms of OAB increase in patients who have experienced COVID-19, and that these symptoms include LUTS, such as urgency, increased frequency and nocturia (Can, Erkoc, et al, 2021;Dhar et al, 2020;Lamb et al, 2022).…”

“…Although nocturia is defined as waking up at night and having to urinate at least once, it is among the most common lower urinary system symptoms (LUTS) that mostly affect the quality of life (Pesonen et al., 2020). Nocturia may be the first symptom of various hypervolemic states, age‐related changes in medications, changes in lifestyle and sleep quality, as well as serious systemic cardiovascular, respiratory, endocrine and metabolic diseases (Culha et al., 2021; Dutoglu et al., 2019). There is a lack of standardisation in defining the causes of nocturia (Graham Jr. et al., 2014).…”